Cardiotrophin 1: Difference between revisions
CSV import Tag: Reverted |
No edit summary Tag: Manual revert |
||
| Line 30: | Line 30: | ||
{{protein-stub}} | {{protein-stub}} | ||
{{No image}} | {{No image}} | ||
Latest revision as of 17:15, 18 March 2025
Cardiotrophin 1 (CT-1) is a cytokine protein that is part of the interleukin 6 (IL-6) family. It is encoded in humans by the CTF1 gene. Cardiotrophin 1 is known for its role in cardiac development and function, as well as its involvement in various pathophysiological processes.
Function[edit]
Cardiotrophin 1 is a secreted protein that signals through the glycoprotein 130 (gp130)/leukemia inhibitory factor receptor (LIFR) complex. It is involved in a variety of biological processes, including cell proliferation, cell differentiation, and apoptosis. CT-1 is particularly important in the heart, where it promotes cardiomyocyte survival and growth, and helps to regulate the heart's response to damage or stress.
Clinical significance[edit]
Alterations in the expression or function of cardiotrophin 1 have been implicated in a number of diseases. For example, elevated levels of CT-1 have been found in patients with heart failure, suggesting that it may play a role in the pathogenesis of this condition. In addition, studies have shown that CT-1 can promote the survival of neurons, suggesting potential therapeutic applications in neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.
Research[edit]
Research into cardiotrophin 1 is ongoing, with studies investigating its role in various diseases and potential therapeutic applications. For example, researchers are exploring the possibility of using CT-1 as a treatment for heart failure, based on its ability to promote cardiomyocyte survival and growth.
See also[edit]
References[edit]
<references group="" responsive="1"></references>
